Jinling Chen

Title: Jinling Chen: Innovator in Pharmaceutical Dosage Forms

Introduction

Jinling Chen is a notable inventor based in Houston, Texas. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms. Her work has implications for the manufacturing and composition of important pharmaceutical compounds.

Latest Patents

Jinling Chen holds a patent for solid dosage forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate. This patent discloses methods of making these dosage forms and compositions useful in their manufacture. The compound, known as telotristat, is significant in the pharmaceutical industry.

Career Highlights

Throughout her career, Jinling Chen has worked with prominent companies in the pharmaceutical sector. She has been associated with Tersera Therapeutics LLC and Lexicon Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in drug formulation and development.

Collaborations

Jinling has collaborated with notable professionals in her field, including Matthew S. Deaver and Richard J. Holl. These collaborations have further enhanced her contributions to pharmaceutical innovations.

Conclusion

Jinling Chen is a distinguished inventor whose work in solid dosage forms has made a significant impact on the pharmaceutical industry. Her patents and collaborations reflect her dedication to advancing drug formulation technologies.